Verifying…
Home / Drug A–Z / Swe-Care Syphilis Rapid Test Kits

Swe-Care Syphilis Rapid Test Kits

NAFDAC Reg. No. A3-101207 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Swe-Care Syphilis Rapid Test Kits
NAFDAC number
A3-101207
Active ingredient
Test Kit
Strength
NA
Form
NA
Pack size
50's
Manufacturer
Not listed
Applicant (holder)
Nolly V. Global Nig Ltd
Approved
31 Mar 2024
Status
Active View on NAFDAC ↗
Registration valid to
25 Mar 2029
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Swe-Care Syphilis Rapid Test Kits is on the NAFDAC register with an active registration (A3-101207). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Swe-Care Syphilis Rapid Test Kits is used for

From the official U.S. FDA label for test kit, the active ingredient registered with NAFDAC.

Boxed warning: RISK OF SEVERE BRONCHOSPASM Mannitol, the active ingredient in ARIDOL, acts as a bronchoconstrictor and may cause severe bronchospasm. Bronchial challenge testing with ARIDOL is for diagnostic purposes only. Bronchial challenge testing with ARIDOL should only be conducted by trained professionals under the supervision of a physician familiar with all aspects of the bronchial challenge test and the management of acute bronchospasm. …
What it is used for

ARIDOL is indicated for the assessment of bronchial hyperresponsiveness in adult and pediatric patients 6 years of age or older who do not have clinically apparent asthma. Limitations of Use: ARIDOL is not a standalone test or a screening test for asthma. Bronchial challenge testing with ARIDOL should be used only as part of a physician's overall assessment of asthma. ARIDOL is a sugar alcohol indicated for the assessment of bronchial hyperresponsiveness in adult and pediatric patients 6 years of age or older who do not have clinically apparent asthma. ( 1 ) Limitations of Use: ARIDOL is not a standalone test or a screening test for asthma. …

Possible side effects

The following clinically significant adverse reaction is described elsewhere in the labeling: • Severe Bronchospasm [ see Warnings and Precautions ( 5.1 )]. Most common adverse reactions (rate ≥1%) were headache, pharyngolaryngeal pain, throat irritation, nausea, cough, rhinorrhea, dyspnea, chest discomfort, wheezing, retching and dizziness. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Methapharm, Inc. …

Do not use if

ARIDOL is contraindicated in: Patients with known hypersensitivity to mannitol or to the gelatin used to make the capsules Patients with conditions that may be compromised by induced bronchospasm or repeated spirometry maneuvers. Some examples include: aortic or cerebral aneurysm, uncontrolled hypertension, recent myocardial infarction or cerebral vascular accident [ see Warnings and Precautions ( 5.2 )]. …

Warnings

& PRECAUTIONS Severe bronchospasm: ARIDOL may cause severe bronchospasm in susceptible patients. Administer by trained professionals under the supervision of a physician. Medications and equipment to treat severe bronchospasm must be present in the testing area. ( 5.1 ) Subjects with co-morbid conditions: Use with caution in patients with conditions that may increase sensitivity to the bronchoconstricting or other potential effects of ARIDOL such as: severe cough, ventilatory impairment, unstable angina, or active upper or lower respiratory tract infection that may worsen with use of a bronchial irritant. …

Pregnancy & breastfeeding

8.1 Pregnancy Risk Summary There are no available human data regarding inhaled mannitol to evaluate a drug-associated risk for major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Based on animal reproduction studies, no evidence of structural alterations was observed when mannitol was orally administered to pregnant rats and mice during organogenesis at doses up to approximately 20 and 10 times, respectively, the maximu …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

NAFDAC recall & alert notices

Public Alert No. 033/2024 – Alert on the Recall of Radox Care + Moisturise Liquid Hand Wash due to presence of Butyphenyl Methylpropional (BMHCA) Content22 Aug 2024 · nafdac.gov.ngThe National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of Radox Care + Moisturise Liquid Hand Wash by the European Union (EU) in Brussels, Belgium.The product does not comply with the Cosmetic Products Regulation as it is said to contain Butyphenyl Methylpropion…Public Alert No.022/2021 – Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators – Letter to Health Care Personnel and Facilities8 Jul 2021 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that the U.S. Food and Drug Administration (FDA) is recommending health care personnel and facilities to transition away from crisis capacity conservation strategies, such as using non-NIOSH-approved disposable respirators, in…Important Covid-19 Vaccine Safety Communication To Healthcare Providers27 May 2021 · nafdac.gov.ng, Important Covid-19 Vaccine Safety Communication To Healthcare Providers KEY POINTS    Possible Rare Event, Severe Allergic Reactions (Anaphylaxis) and Thromboembolic Events with Some Covid-19 Vaccines (probably due to underlying medical conditions and use of certain medications). Possible contraindications with Non…Public Alert No: 39/2020 – Alert on Happy Ducts Compress, Cord Care and Goldenseal Powder by WishGarden Herbs Due to Bacterial Contamination30 Dec 2020 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from the US FDA about voluntary recall of some lots of Happy Ducts Compress, Cord Care and Goldenseal Powder by WishGarden Herbs. The recall is due to a possible supply chain contamination with the bacteria Cronobacter …

Notices list affected brands and batch numbers — compare them with your pack. Enter your batch number above to check it automatically.

Check your pack of Swe-Care Syphilis Rapid Test Kits

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Swe-Care Syphilis Rapid Test Kits

What is in Swe-Care Syphilis Rapid Test Kits?

Swe-Care Syphilis Rapid Test Kits contains Test Kit (NA), as na, according to its NAFDAC registration record.

Is Swe-Care Syphilis Rapid Test Kits registered with NAFDAC?

Yes. Swe-Care Syphilis Rapid Test Kits is listed on the NAFDAC register under registration number A3-101207, and its registration is active as of 5 November 2026.

Has Swe-Care Syphilis Rapid Test Kits been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Swe-Care Syphilis Rapid Test Kits in our automatically synced alert list.

How can I check that my pack of Swe-Care Syphilis Rapid Test Kits is genuine?

Run a free authenticity scan with the NAFDAC number A3-101207, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Swe-Care Syphilis Rapid Test Kits used for?

ARIDOL is indicated for the assessment of bronchial hyperresponsiveness in adult and pediatric patients 6 years of age or older who do not have clinically apparent asthma. Limitations of Use: ARIDOL is not a standalone test or a screening test for asthma. Bronchial challenge testing with ARIDOL should be used only as part of a physician's overall assessment of asthma. ARIDOL is a sugar alcohol ind (Summarised from the official U.S. FDA label for test kit. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Swe-Care Syphilis Rapid Test Kits? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.